BUDAPEST — Eurofins Technologies launched several testing kits for detecting if manufacturing employees have been exposed to or infected with COVID-19. The tests are intended to help essential businesses determine how their workforces are impacted by the virus.
Serological testing, which uses blood samples to identify pathogens, may supplement swab testing for employees who express symptoms but have not tested positive for COVID-19. The range of testing kits was developed with affiliate companies Gold Standard Diagnostics Inc., VIROTECH Diagnostics GmbH, NovaTec Immundiagnostica GmbH and Ingenasa.
“This launch is the result of the strong devotion of our scientists to our fight against COVID-19,” said Gilles Martin, chief executive officer of Eurofins Technologies. “They worked round the clock over the last six weeks to develop and optimize tests with very high specificity. This is important in order to minimize risks of false positive detections. We are very pleased to provide this additional testing option.”
The company and its partners are ramping up to produce kits to carry out as many as 10 million tests per month, Mr. Martin said. Tests began shipping April 17.